Malavika Deodhar

767 total citations
15 papers, 495 citations indexed

About

Malavika Deodhar is a scholar working on Pharmacology, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Malavika Deodhar has authored 15 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Geriatrics and Gerontology and 2 papers in Molecular Biology. Recurrent topics in Malavika Deodhar's work include Pharmacogenetics and Drug Metabolism (5 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Pain Management and Opioid Use (2 papers). Malavika Deodhar is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Pain Management and Opioid Use (2 papers). Malavika Deodhar collaborates with scholars based in United States and Canada. Malavika Deodhar's co-authors include Jacques Turgeon, Véronique Michaud, Sweilem B. Al Rihani, Lucy I. Darakjian, Pamela Dow, Meghan J. Arwood, Stephanie A. Matthews, Timothy A. Simeone, Kristina A. Simeone and Brian Cicali and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and European Journal of Pharmacology.

In The Last Decade

Malavika Deodhar

15 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malavika Deodhar United States	12	111	97	77	63	56	15	495
Sweilem B. Al Rihani United States	13	200 1.8×	81 0.8×	39 0.5×	126 2.0×	99 1.8×	18	695
Pamela Dow Canada	7	64 0.6×	73 0.8×	23 0.3×	48 0.8×	38 0.7×	13	320
Deepak Gopal Shewade India	17	129 1.2×	198 2.0×	55 0.7×	106 1.7×	102 1.8×	68	708
Smita Pattanaik India	12	64 0.6×	141 1.5×	57 0.7×	18 0.3×	53 0.9×	43	454
Chandrasekaran Adithan India	14	82 0.7×	154 1.6×	33 0.4×	81 1.3×	55 1.0×	27	597
Lucy I. Darakjian United States	8	91 0.8×	90 0.9×	37 0.5×	58 0.9×	61 1.1×	11	406
Augusto Filipe Spain	10	147 1.3×	46 0.5×	51 0.7×	27 0.4×	100 1.8×	38	607
Mikael Boberg Sweden	6	95 0.9×	132 1.4×	48 0.6×	67 1.1×	54 1.0×	12	371
Naina Mohamed Pakkir Maideen United Arab Emirates	12	89 0.8×	85 0.9×	17 0.2×	42 0.7×	54 1.0×	59	459
Mohamed E. E. Shams Egypt	15	187 1.7×	171 1.8×	231 3.0×	58 0.9×	158 2.8×	32	904

Countries citing papers authored by Malavika Deodhar

Since Specialization

Citations

This map shows the geographic impact of Malavika Deodhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malavika Deodhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malavika Deodhar more than expected).

Fields of papers citing papers by Malavika Deodhar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malavika Deodhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malavika Deodhar. The network helps show where Malavika Deodhar may publish in the future.

Co-authorship network of co-authors of Malavika Deodhar

This figure shows the co-authorship network connecting the top 25 collaborators of Malavika Deodhar. A scholar is included among the top collaborators of Malavika Deodhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malavika Deodhar. Malavika Deodhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Robinson, William H., David Fiorentino, Leland W.K. Chung, et al.. (2024). Cutting-edge approaches to B-cell depletion in autoimmune diseases. Frontiers in Immunology. 15. 1454747–1454747. 13 indexed citations

Deodhar, Malavika, et al.. (2021). Pharmacoresponsiveness of spontaneous recurrent seizures and the comorbid sleep disorder of epileptic Kcna1-null mice. European Journal of Pharmacology. 913. 174656–174656. 7 indexed citations

Deodhar, Malavika, Sweilem B. Al Rihani, Lucy I. Darakjian, Jacques Turgeon, & Véronique Michaud. (2021). Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition. Pharmaceutics. 13(2). 148–148. 47 indexed citations

Darakjian, Lucy I., Malavika Deodhar, Jacques Turgeon, & Véronique Michaud. (2021). Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity. International Journal of Molecular Sciences. 22(9). 4967–4967. 39 indexed citations

Rihani, Sweilem B. Al, Malavika Deodhar, Lucy I. Darakjian, et al.. (2021). Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models. Drugs & Aging. 38(11). 977–994. 41 indexed citations

Michaud, Véronique, Pamela Dow, Lucy I. Darakjian, et al.. (2021). Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare Costs. Journal of Personalized Medicine. 11(11). 1174–1174. 5 indexed citations

Rihani, Sweilem B. Al, Lucy I. Darakjian, Malavika Deodhar, et al.. (2021). Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level. International Journal of Molecular Sciences. 22(7). 3742–3742. 35 indexed citations

Deodhar, Malavika, Jacques Turgeon, & Véronique Michaud. (2021). Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism. Pharmaceutics. 13(9). 1466–1466. 16 indexed citations

Rihani, Sweilem B. Al, et al.. (2021). Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study. Clinical and Translational Science. 14(5). 1799–1809. 4 indexed citations

10.

Michaud, Véronique, Pamela Dow, Sweilem B. Al Rihani, et al.. (2020). Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs. Clinical and Translational Science. 14(1). 20–28. 36 indexed citations

11.

Michaud, Véronique, Malavika Deodhar, Meghan J. Arwood, et al.. (2020). ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System. Journal of Clinical Medicine. 9(7). 2096–2096. 28 indexed citations

12.

Deodhar, Malavika, Sweilem B. Al Rihani, Meghan J. Arwood, et al.. (2020). Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice. Pharmaceutics. 12(9). 846–846. 140 indexed citations

13.

Rihani, Sweilem B. Al, et al.. (2020). Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy. Journal of Clinical Medicine. 9(8). 2591–2591. 14 indexed citations

14.

Deodhar, Malavika, et al.. (2018). Ketogenic diet regulates the antioxidant catalase via the transcription factor PPARγ2. Epilepsy Research. 147. 71–74. 24 indexed citations

15.

Simeone, Kristina A., Charles S. Bockman, Stephanie A. Matthews, et al.. (2018). Respiratory dysfunction progresses with age in Kcna1‐null mice, a model of sudden unexpected death in epilepsy. Epilepsia. 59(2). 345–357. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact